NIOSH Pauses Federal Black Lung Screening Program for Coal Miners
NIOSH announced it will not be accepting new patient requests related specifically to the Coal Workers’ Health Surveillance Program (CWHSP).
Read moreMain Content
Bipartisan "Cures 2.1" White Paper Released in Waning Days of Last Congress
Jan. 10, 2025
U.S. Rep. Diana DeGette (D-CO) and former Rep. Larry Buchson (R-IN) released a 21st Century Cures 2.1 white paper Dec. 24, containing recommendations for consideration in the 119th Congress. The American College of Radiology® (ACR®) provided comments informing the document last summer.
The 21st Century Cures Act (2016) addressed topics related to software oversight, data sharing, biomedical research funding and payment policy. Congress began to examine Cures Act-related gaps and opportunities in 2019, an effort that was coined “Cures 2.0,” and ultimately helped establish the Advanced Research Projects Agency for Health (ARPA-H).
The latest white paper, “A Roadmap for 21st Century Cures Next Steps for the Cures 2.0 Act and the 21st Century Cures Initiative,” suggests focus areas for future Cures-related legislative activities, including changes to Medicare payment policy and local coverage determination processes, U.S. Preventive Services Task Force processes, clinical trials access, health information exchange, software/medical device oversight, and more.
ACR members with questions about Cures 2.0 can contact Michael Peters, ACR Senior Director, Government Relations, or Katie Grady, ACR Government Affairs Director.
The 21st Century Cures Act (2016) addressed topics related to software oversight, data sharing, biomedical research funding and payment policy. Congress began to examine Cures Act-related gaps and opportunities in 2019, an effort that was coined “Cures 2.0,” and ultimately helped establish the Advanced Research Projects Agency for Health (ARPA-H).
The latest white paper, “A Roadmap for 21st Century Cures Next Steps for the Cures 2.0 Act and the 21st Century Cures Initiative,” suggests focus areas for future Cures-related legislative activities, including changes to Medicare payment policy and local coverage determination processes, U.S. Preventive Services Task Force processes, clinical trials access, health information exchange, software/medical device oversight, and more.
ACR members with questions about Cures 2.0 can contact Michael Peters, ACR Senior Director, Government Relations, or Katie Grady, ACR Government Affairs Director.
Related ACR News
PA Radiological Society Claims Trophy at ACR 2025 Healthcare AI Challenge
The Pennsylvania Radiological Society walked away as ChAIpter Challenge winner during ACR 2025.
Read more“White Coat” Radiologists Have Their Voice Heard on Capitol Hill
More than 450 lab-coat-clad “radvocates” took to Capitol Hill as part of the annual “Hill Day” activities during ACR 2025.
Read more